THE EFFECTS OF CATECHOL ON THE URINARY-BLADDER OF RATS TREATED WITH-N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE

Authors:
  • ELEJ LAVOIE
    EJ LAVOIE
  • ASA SHIGEMATSU
    A SHIGEMATSU
  • BMB MU
    B MU
  • ARA RIVENSON
    A RIVENSON
  • DHD HOFFMANN
    D HOFFMANN

  • 1 January 1985
    • journal article
    • research article
    • Vol. 76  (4) , 266-271
    • PMID:3924700
Abstract
The effect of catechol on the development of urinary bladder tumors in Fischer rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) was studied. A solution of 0.05% catechol and 0.001% BBN was administered in the drinking water ad lib for 78 wk. The urinary bladders were then removed and examined microscopically. No statistically significantly difference was observed between the experimental group receiving 0.001% BBN with 0.05% catechol and animals receiving 0.001% BBN alone with respect to the incidence of hyperplasia, papilloma, or carcinoma of the urinary bladder. Animals receiving 0.05% catechol alone in the drinking water had no macroscopic or microscopic lesions significantly different from those in control animals receiving tap water. Analyses of the urine of animals receiving catechol in their drinking water indicated that > 99% of the catechol present was in the form of either glucuronide or sulfate conjugates. In a 2nd bioassay, the potential cocarcinogenicity of catechol, administered together with BBN, was explored by direct instillation into the urinary bladder. The development of calculi and possible infections of the urinary tract within all groups of treated animals suggests that this bioassay technique for cocarcinogenicity is of questionable value. These data show that catechol at the dose and mode of administration employed did not affect the epithelium of the urinary bladder or enhance the carcinogenic activity of BBN.